Key Therapeutic Uses Control of fasting and postprandial blood glucose levels Monotherapy in patients who cannot tolerate metformin Add-on therapy with metformin, sulfonylureas, insulin, or other antidiabetic medicines Suitable for patients with mild to moderate renal impairment (dose adjusted as advised) It is not recommended for the treatment of Type 1 diabetes or diabetic ketoacidosis
The contribution of IL-17 to the development of autoimmunity in psoriasis
Your body mass index (BMI) at the start of treatment will also affect how quickly you see results from lipotropic injections
For metabolite clustering analysis, average linkage hierarchical clustering was performed in the Statistical Analysis module of MetaboAnalyst 6.0 using Euclidian distance as a similarity metric
Reference Carton, Bouletreau, van Alphen, van Lenteren, Ashburner, Carson and Thompson1986, Reference Carton, Poirie and Nappi2008